Table 2 Recurrence status (r0) prior to endoscopic nasopharyngectomy
From: 5-year outcomes of salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma
Patient # | r0TNM | r0Stage | Location of recurrence | Surgical margins | Adjuvant therapy |
|---|---|---|---|---|---|
P1 | T2N1M0 | Stage 2 | Nasopharynx, parapharyngeal space | + (fossa of Rosenmuller) | CyberKnife SRT (12Gy) + Chemo (docetaxel, cisplatin, 5-FU) |
P2 | T1N0M0 | Stage 1 | Nasopharynx | – | None |
P3 | T1N0M0 | Stage 1 | Nasopharynx, nasal cavity | – | None |
P4 | T2N0M0 | Stage 2 | Nasopharynx, parapharyngeal space | + (parapharyngeal space) | CyberKnife SRT (12Gy) |
P5 | T1N0M0 | Stage 1 | Nasopharynx | – | None |
P6 | T1N0M0 | Stage 1 | Nasopharynx, nasal cavity | – | None |
P7 | T1N0M0 | Stage 1 | Nasopharynx | – | None |
P8 | T3N0M0 | Stage 3 | Nasopharynx, sphenoid sinus | – | None |
P9 | T1N0M0 | Stage 1 | Nasopharynx | – | None |
P10 | T1N1M0 | Stage 2 | Nasopharynx, oropharynx | + (oropharynx) | IMRT (60 Gy) + Chemo (cetuximab) |
P11 | T3N0M0 | Stage 3 | Nasopharynx, floor of sphenoid sinus | – | None |
P12 | T1N0M0 | Stage 1 | Nasopharynx | – | Brachytherapy |
P13 | T1N0M0 | Stage 1 | Nasopharynx | – | None |